» Articles » PMID: 22740230

Structural and Functional Conservation of CLEC-2 with the Species-specific Regulation of Transcript Expression in Evolution

Overview
Journal Glycoconj J
Publisher Springer
Date 2012 Jun 29
PMID 22740230
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

CLEC-2 was first identified by sequence similarity to C-type lectin-like molecules with immune functions and has been reported as a receptor for the platelet-aggregating snake venom toxin rhodocytin and the endogenous sialoglycoprotein podoplanin. Recent researches indicate that CLEC-2-deficient mice were lethal at the embryonic stage associated with disorganized and blood-filled lymphatic vessels and severe edema. In view of a necessary role of CLEC-2 in the individual development, it is of interest to investigate its phylogenetic homology and highly conserved functional regions. In this work, we reported that CLEC-2 from different species holds with an extraordinary conservation by sequence alignment and phylogenetic tree analysis. The functional structures including N-linked oligosaccharide sites and ligand-binding domain implement a structural and functional conservation in a variety of species. The glycosylation sites (N120 and N134) are necessary for the surface expression CLEC-2. CLEC-2 from different species possesses the binding activity of mouse podoplanin. Nevertheless, the expression of CLEC-2 is regulated with a species-specific manner. The alternative splicing of pre-mRNA, a regulatory mechanism of gene expression, and the binding sites on promoter for several key transcription factors vary between different species. Therefore, CLEC-2 shares high sequence homology and functional identity. However the transcript expression might be tightly regulated by different mechanisms in evolution.

Citing Articles

C-type lectin-like receptor (CLEC)-2, the ligand of podoplanin, induces morphological changes in podocytes.

Tanaka K, Tanaka M, Watanabe N, Ito M, Pastan I, Koizumi M Sci Rep. 2022; 12(1):22356.

PMID: 36572741 PMC: 9792514. DOI: 10.1038/s41598-022-26456-9.


Cobalt hematoporphyrin inhibits CLEC-2-podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice.

Tsukiji N, Osada M, Sasaki T, Shirai T, Satoh K, Inoue O Blood Adv. 2018; 2(17):2214-2225.

PMID: 30190281 PMC: 6134222. DOI: 10.1182/bloodadvances.2018016261.


The snake venom rhodocytin from Calloselasma rhodostoma- a clinically important toxin and a useful experimental tool for studies of C-type lectin-like receptor 2 (CLEC-2).

Bruserud O Toxins (Basel). 2013; 5(4):665-74.

PMID: 23594438 PMC: 3705285. DOI: 10.3390/toxins5040665.


The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.

Xie J Glycoconj J. 2012; 29(5-6):273-84.

PMID: 22791411 DOI: 10.1007/s10719-012-9419-9.

References
1.
Sobanov Y, Bernreiter A, Derdak S, Mechtcheriakova D, Schweighofer B, Duchler M . A novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complex. Eur J Immunol. 2001; 31(12):3493-503. DOI: 10.1002/1521-4141(200112)31:12<3493::aid-immu3493>3.0.co;2-9. View

2.
Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D . Function of alternative splicing. Gene. 2005; 344:1-20. DOI: 10.1016/j.gene.2004.10.022. View

3.
Xie J, Wu T, Guo L, Ruan Y, Zhou L, Zhu H . Molecular characterization of two novel isoforms and a soluble form of mouse CLEC-2. Biochem Biophys Res Commun. 2008; 371(2):180-4. DOI: 10.1016/j.bbrc.2008.03.070. View

4.
Visvader J, Elefanty A, Strasser A, Adams J . GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid line. EMBO J. 1992; 11(12):4557-64. PMC: 557031. DOI: 10.1002/j.1460-2075.1992.tb05557.x. View

5.
Osorio F, Reis e Sousa C . Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity. 2011; 34(5):651-64. DOI: 10.1016/j.immuni.2011.05.001. View